No significant differences were found in terms of age, hypertension, SBP, DBP, the usage of calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACEI), β blockers, oral hypoglycemia agents, and statin (all P for trend > 0.05) (Table 1). Here, ACE is linked to hypertensive disorder.